SuperGen's MP-470 Sensitizes Prostate and Breast Cancer Cells to... ( Data support MP-470's role in ...)

SuperGen's MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib

Date:4/14/2008

Data support MP-470's role in overcoming erlotinib resistance

DUBLIN, Calif., April 14 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced as part of a series of presentations at the 2008 AACR Annual Meeting that MP-470 effectively sensitizes prostate and breast cancer cells to erlotinib (Abstract No. 671).

Entitled, "Inhibition of erlotinib resistance on HER-family tyrosine kinases by combination with MP-470, a multi-targeted TK inhibitor in prostate and breast cancer," the poster highlights data indicating that the combination of MP-470 and erlotinib inhibits the binding of the p85 subunit of PI3K, and has a greater impact than either agent alone in reducing phosphorylation of Akt, ERK1/2, EGFR/HER1, HER2/Neu, and HER3.

"These data build upon previous results showing that MP-470 exhibits anti-tumor activity in breast and prostate cancer cells," said Dr. David Bearss, SuperGen's Vice President and Chief Scientist. "The fact that MP-470 in combination with erlotinib effectively suppressed the HER pathway suggests that concurrent administration of both compounds could represent a new treatment for prostate and breast cancers. We will continue to explore this synergy as we develop further MP-470."

Copies of the 2008 AACR Annual Meeting poster presentations will be available in the pipeline section of SuperGen's Web site http://www.supergen.com.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development an
'/>"/>

SOURCE SuperGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
3. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
6. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
7. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
8. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
11. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer

Post Your Comments:

(Date:12/1/2009)...UREL, N.J., Dec. 1 Med... technology-enabled clinical documentation service...from Primordial Design, Inc. has been integrated w...e speech recognition system. The solution is being... America (RSNA) convention November 29 through Dec...

(Date:12/1/2009)..., TAI,AN, China, Dec. 1 /PRNewswire-Asia-Firs...tin Board: CBPO) (Nasdaq: CBPO ) ("China Biologic...sed biopharmaceutical companies in,China, today an...list its,common stock on the NASDAQ Global Market....egin trading on the NASDAQ on,Wednesday, December ...

(Date:12/1/2009)...GEWATER, N.J., Dec. 1 Tibotec Ther...ducts, L.P., announced today that it is launching ...cting women and people of color living with HIV/AI...al educational events, media outreach and a new We...aring learnings from the GRACE study, the largest ...

Breaking Medicine Technology:MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2 China Biologic Products Approved to List on NASDAQ 2 China Biologic Products Approved to List on NASDAQ 3 Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2 Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3 Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4 Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5 Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6 Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7 Public Private Partnerships Key to Achieving Global Food Security Says DuPont Leader 14610 1 Public Private Partnerships Key to Achieving Global Food Security Says DuPont Leader 14610 2 Public Private Partnerships Key to Achieving Global Food Security Says DuPont Leader 14610 3 Radiation From Medical Scans Soaring 60144 1 Radiation From Medical Scans Soaring 60144 2 Radiation From Medical Scans Soaring 60144 3 Susan G Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 60141 1 Susan G Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 60141 2 Susan G Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 60141 3 Susan G Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 60141 4

[0] MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology [0] China Biologic Products Approved to List on NASDAQ [0] Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS

...sta,Therapeutics, Inc. (Amex: SYI ) today announc... proprietary monoclonal enzyme immunoassay can,det...ss than two hours, and,can aid physicians in predi...s. The study was presented today at the 2008 Cardi...sium in Bethesda, Maryland., "This study shows th...

...de range of symptoms of ADHD, DURHAM, N.C., Sept....ivity to stress has been shown to significantly re...isorder (ADHD) in children,according to a phase 3 ...ls., The study showed that the new drug, Clonicel...ver placebo in reducing an aggregate of 18 ADHD,sy...

Other Medicine Technology:Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes 2 Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes 3 Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes 4 Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD 2 Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD 3

Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD

(Date:12/1/2009)... For many employers, the issue of q...just an employee benefit, it,s providing for the n...res, Inc. is leading this effort, with the help of...ess center at its corporate offices, bringing qual...o employees and their dependents. ,, Beginni...

(Date:12/1/2009)... 1 , - At ECPA,s Food Sup...tion and Modes of Agriculture Will Require Science... Chief Scientific Adviser to the UK government,as...d on science and have a,sound evidence basis. "Hav...lity to look at all stages of policy development h...

(Date:12/1/2009)...ess to treatment worldwide provide reasons for hop...- While the war against HIV/AIDS is still far from...terms of advances in prevention and treatment, exp...d Nations report found that the number of people i...at about 33 million, for the past two years, and m...

(Date:12/1/2009)...rs for Disease Control (CDC) estimates that 1 in 1...utism spectrum disorder. These children can learn ...by playing the new therapeutic PC video game EASe ...wonderful holiday gift idea for a child on the aut... (PRWEB) December 1, 2009 -- The new therapeutic P...

(Date:12/1/2009)... physician Dr. Michael Aziz announces the release ...Diet: 10 Key Hormones that Hold the Secret to Losi...books Jan. 2110). The book delivers a powerful mes...urb hormones, and promises a dramatic jump-start t...s. , New York, NY (PRWEB)...

Breaking Medicine News(10 mins):Health News:Hobby Lobby Selects Concentra to Open Health Center 2 Health News:Hobby Lobby Selects Concentra to Open Health Center 3 Health News:Food Security to be the Top Issue for EU's Science Chief 2 Health News:A Good Year in the Fight Against AIDS 2 Health News:A Good Year in the Fight Against AIDS 3 Health News:A Good Year in the Fight Against AIDS 4 Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 2 Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 3 Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 4 Health News:Dr. Michael Aziz Releases a New Nutrition Book That Debunks Most Popular Diets and Diet Books 2 Health News:Dr. Michael Aziz Releases a New Nutrition Book That Debunks Most Popular Diets and Diet Books 3

[0] Hobby Lobby Selects Concentra to Open Health Center [0] Food Security to be the Top Issue for EU's Science Chief [0] A Good Year in the Fight Against AIDS [0] EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing [1] Dr. Michael Aziz Releases a New Nutrition Book That Debunks Most Popular Diets and Diet Books

...AST RUTHERFORD, N.J., Feb. 14 Cambrex,Corporation...r 2007 results,for the period ended December 31, 2...prnh/20000613/CAMBREXLOGO ), Summary, -- Fourt...excluding foreign currency) compared to 2006. -- ...

...EW YORK, Feb. 14 National Penn Bancshares Inc. (N...c. (NYSE: BDY ) in the S&P,SmallCap 600 after the...BDY,is being acquired in a deal expected to close ...//www.standardandpoors.com ., National Penn Bancs...

...ASHINGTON, Feb. 14 The American people,through th...), have,launched a five-year, $60 million program ...th called Family Advancement for Life and Health (...y and,explores new solutions to the many challenge...

... COLLEGE STATION Diabetes can be a killer, but t...searchers could lead to new ways to study and figh... high blood glucose (sugar) levels, they also have... acid aspects of diabetes separately because there...

...EW YORK, Feb. 14 His Royal Highness, The Duke of ... to mark the United States,launch of UK-based spec...,(LSE: PSK). ProStrakan,s first US product, Sancus...1 ), Prince Andrew is visiting the United States...

...OUSTON and OTTAWA, Feb. 14 Following the,company,...,461,000 for 2007,at its sports and nutritional pr...n International, Inc., http://www.interactivenutr...it of its common stock.,Each shareholder will rece...

Cambrex Reports Fourth Quarter and Full-Year 2007 Results Standard & Poor's Announces Change to U.S. Index USAID Launches a $60 Million Child-Spacing and Reproductive-Health Program in Pakistan Research findings may lead to new ways to study and fight diabetes His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States Natural Nutrition Announces Effectiveness of Forward Split of Common Stock Following 2007 Record Revenue Year

...ors angled at 76°, 66° and 60°. The G...l and peripheral fundus viewing and treatment. Th...d spaced 120° apart to eliminate "gaps" in the...ns also provides direct observation of the central...

...cond mirror adds, then you may want to consider th...agnification as the G-1 but offers two opposing mi...in standard (flange) or new glass NF (no-flange/no...l for laser use. Provides broader views of the a...

...e a family of single-use direct view vitrectomy le...of the retinal surface during eye surgery. The con...ormed and polished to interface effectively with t... boxes of 10 and are individually packaged in a du...

Direct Image 45° Prism SSV®

Medicine Products:

G-3 goniofundus G-2 trabeculum Disposable Vitrectomy Lens Direct Image 45° Prism SSV®

SuperGen's MP-470 Sensitizes Prostate and Breast Cancer Cells to...( Data support MP-470's role in ...),Health